Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
Resource Type
Article
Authors
Ferrante, Marc ; Panaccione, Remo ; Baert, Filip ; Bossuyt, Peter ; Colombel, Jean-Frederic ; Danese, Silvio ; Dubinsky, Marla ; Feagan, Brian G ; Hisamatsu, Tadakazu ; Lim, Allen ; Lindsay, James O ; Loftus, Edward V, Jr ; Panés, Julián ; Peyrin-Biroulet, Laurent ; Ran, Zhihua ; Rubin, David T ; Sandborn, William J ; Schreiber, Stefan ; Neimark, Ezequiel ; Song, Alexandra ; Kligys, Kristina ; Pang, Yinuo ; Pivorunas, Valerie ; Berg, Sofie ; Duan, W Rachel ; Huang, Bidan ; Kalabic, Jasmina ; Liao, Xiaomei ; Robinson, Anne ; Wallace, Kori ; D'Haens, Geert
Source
In The Lancet 28 May-3 June 2022 399(10340):2031-2046
Subject
Primary Research Articles
Language
ISSN
0140-6736